Growing community of inventors

Bondues, France

Carole Belanger

Average Co-Inventor Count = 5.29

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 31

Carole BelangerRobert Walczak (12 patents)Carole BelangerRaphael Darteil (6 patents)Carole BelangerPhilippe Delataille (6 patents)Carole BelangerPierre Daubersies (6 patents)Carole BelangerEmilie Negro (6 patents)Carole BelangerBenoît Noel (4 patents)Carole BelangerCorinne Foucart (3 patents)Carole BelangerEmeline Descamps (3 patents)Carole BelangerGuillaume Vidal (2 patents)Carole BelangerMathilde Walczak (2 patents)Carole BelangerDean Hum (1 patent)Carole BelangerRaphaël Darteil (3 patents)Carole BelangerVanessa Legry (2 patents)Carole BelangerBenoït Noel (1 patent)Carole BelangerIsabelle Delbaere (1 patent)Carole BelangerRaphaël Darteil (0 patent)Carole BelangerCarole Belanger (12 patents)Robert WalczakRobert Walczak (24 patents)Raphael DarteilRaphael Darteil (14 patents)Philippe DelataillePhilippe Delataille (8 patents)Pierre DaubersiesPierre Daubersies (6 patents)Emilie NegroEmilie Negro (6 patents)Benoît NoelBenoît Noel (6 patents)Corinne FoucartCorinne Foucart (5 patents)Emeline DescampsEmeline Descamps (4 patents)Guillaume VidalGuillaume Vidal (2 patents)Mathilde WalczakMathilde Walczak (2 patents)Dean HumDean Hum (10 patents)Raphaël DarteilRaphaël Darteil (3 patents)Vanessa LegryVanessa Legry (3 patents)Benoït NoelBenoït Noel (1 patent)Isabelle DelbaereIsabelle Delbaere (1 patent)Raphaël DarteilRaphaël Darteil (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genfit (12 from 67 patents)


12 patents:

1. 12053456 - Pharmaceutical compositions for combination therapy

2. 11590108 - Pharmaceutical compositions for combination therapy

3. 11484517 - Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor

4. 11478440 - Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent

5. 11191749 - Pharmaceutical compositions for combination therapy

6. 11103484 - Methods of treatment for cholestatic and fibrotic diseases

7. 11033534 - Pharmaceutical compositions for combination therapy

8. 10905680 - Methods of treatment for cholestatic and fibrotic diseases

9. 10130612 - Methods of treatment for cholestatic and fibrotic diseases

10. 10130613 - Methods of treatment for cholestatic and fibrotic diseases

11. 10117855 - Methods of treatment for cholestatic and fibrotic diseases

12. 10117856 - Methods of treatment for cholestatic and fibrotic diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…